KEYNOTE-B15
Phase 3 Completed
808 enrolled
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Phase 1/2 Completed
272 enrolled
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Completed
17 enrolled 12 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Phase 2 Completed
57 enrolled
BLAST
Phase 1 Completed
22 enrolled
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Phase 1/2 Completed
83 enrolled 14 charts
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer
Phase 2 Completed
87 enrolled 13 charts
IMvigor130
Phase 3 Completed
1,213 enrolled 35 charts
PCR-MIB
Phase 2 Completed
28 enrolled 15 charts
IVY
Phase 1 Completed
353 enrolled
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Phase 2 Completed
37 enrolled 19 charts
COXEN
Phase 2 Completed
237 enrolled 20 charts
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Phase 2 Completed
76 enrolled 14 charts
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
Completed
221 enrolled
GAMEC-II
Phase 2 Completed
36 enrolled
B7-Family Score in Urothelial Carcinoma
Completed
215 enrolled
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Phase 3 Completed
506 enrolled 13 charts
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Phase 3 Completed
330 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
490 enrolled
PIVOT-02
Phase 1/2 Completed
557 enrolled 22 charts
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Phase 2 Completed
2 enrolled 8 charts
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
Phase 2 Completed
36 enrolled 12 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
Phase 2 Completed
70 enrolled 18 charts
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
Phase 2 Completed
29 enrolled
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
Phase 2 Completed
43 enrolled 20 charts
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
Phase 2 Completed
6 enrolled
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Phase 2 Completed
108 enrolled
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
Phase 3 Completed
302 enrolled 9 charts
Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
Phase 3 Completed
280 enrolled
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
Phase 2 Completed
53 enrolled
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Phase 2 Completed
121 enrolled 8 charts
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
Phase 2 Completed
22 enrolled 7 charts
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
Phase 2 Completed
45 enrolled
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Phase 2 Completed
51 enrolled 11 charts
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Phase 1 Completed
10 enrolled 14 charts
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)
Phase 2 Completed
63 enrolled
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
Phase 2 Completed
71 enrolled
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
Phase 2 Completed
97 enrolled 8 charts
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Phase 1/2 Completed
15 enrolled
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
16 enrolled
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Phase 3 Completed
67 enrolled
CVH-CT02
Phase 2 Completed
61 enrolled
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
Phase 1 Completed
38 enrolled
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase 2 Completed
36 enrolled 9 charts
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Phase 2 Completed
39 enrolled 7 charts
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Phase 3 Completed
285 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
42 enrolled
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer
Phase 2 Completed
60 enrolled 10 charts